Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Applied Molecular Transport Inc. (AMTI) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Applied Molecular Transport Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1801777.
Total stock buying since 2020: $40,134,334.
Total stock sales since 2020: $11,280,640.
Total stock option exercises since 2020: $237,900.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 1,102,129 | $180,982 | 0 | $0 |
| 2022 | 269,500 | $701,888 | 22,893 | $61,851 | 0 | $0 |
| 2021 | 39,635 | $1,352,446 | 260,500 | $11,037,807 | 67,000 | $221,900 |
| 2020 | 2,720,000 | $38,080,000 | 0 | $0 | 800,000 | $16,000 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-11 | 0 | $0 | 599,209 | $97,560 | 0 | $0 |
| 2023-10 | 0 | $0 | 184,442 | $30,432 | 0 | $0 |
| 2023-09 | 0 | $0 | 305,716 | $48,812 | 0 | $0 |
| 2023-06 | 0 | $0 | 8,501 | $2,047 | 0 | $0 |
| 2023-03 | 0 | $0 | 4,261 | $2,131 | 0 | $0 |
| 2022-11 | 150,000 | $149,700 | 0 | $0 | 0 | $0 |
| 2022-09 | 0 | $0 | 4,424 | $6,279 | 0 | $0 |
| 2022-06 | 0 | $0 | 18,469 | $55,572 | 0 | $0 |
| 2022-05 | 66,500 | $210,850 | 0 | $0 | 0 | $0 |
| 2022-03 | 45,888 | $290,929 | 0 | $0 | 0 | $0 |
| 2022-02 | 4,112 | $26,769 | 0 | $0 | 0 | $0 |
| 2022-01 | 3,000 | $23,640 | 0 | $0 | 0 | $0 |
| 2021-12 | 3,500 | $52,465 | 0 | $0 | 31,500 | $74,970 |
| 2021-11 | 11,135 | $249,981 | 0 | $0 | 0 | $0 |
| 2021-08 | 0 | $0 | 35,000 | $1,060,945 | 10,000 | $46,100 |
| 2021-07 | 0 | $0 | 216,500 | $9,614,180 | 16,500 | $59,340 |
| 2021-04 | 25,000 | $1,050,000 | 9,000 | $362,682 | 9,000 | $41,490 |
| 2020-07 | 0 | $0 | 0 | $0 | 800,000 | $16,000 |
| 2020-06 | 2,720,000 | $38,080,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-22 | Mahmood Tahir Ph.d. (Director) | Sale | 286,320 | .16 | 46,670 |
| 2023-11-22 | Hants Brandon (CFO) | Sale | 61,494 | .16 | 10,085 |
| 2023-11-22 | Cross Shawn (CEO & Chair of the Board) | Sale | 110,802 | .16 | 18,171 |
| 2023-11-15 | Hants Brandon (CFO) | Sale | 50,146 | .16 | 8,073 |
| 2023-11-15 | Cross Shawn (CEO & Chair of the Board) | Sale | 90,447 | .16 | 14,561 |
| 2023-10-06 | Mahmood Tahir Ph.d. (Director) | Sale | 184,442 | .17 | 30,432 |
| 2023-09-29 | Hants Brandon (CFO) | Sale | 107,540 | .16 | 17,098 |
| 2023-09-29 | Cross Shawn (CEO & Chair of the Board) | Sale | 193,960 | .16 | 30,839 |
| 2023-09-05 | Mahmood Tahir Ph.d. (Director) | Sale | 2,245 | .21 | 466 |
| 2023-09-05 | Hants Brandon (CFO) | Sale | 718 | .21 | 149 |
| 2023-09-05 | Cross Shawn (CEO & Chair of the Board) | Sale | 1,253 | .21 | 260 |
| 2023-06-02 | Mahmood Tahir Ph.d. (Director) | Sale | 1,992 | .24 | 480 |
| 2023-06-02 | Hants Brandon (CFO) | Sale | 2,203 | .24 | 530 |
| 2023-06-02 | Cross Shawn (CEO & Chair of the Board) | Sale | 4,306 | .24 | 1,037 |
| 2023-03-01 | Kanwar Bittoo (Chief Medical Officer) | Sale | 539 | .50 | 270 |
| 2023-03-01 | Mahmood Tahir Ph.d. (Chief Executive Officer) | Sale | 1,802 | .50 | 901 |
| 2023-03-01 | Hants Brandon (CFO) | Sale | 504 | .50 | 252 |
| 2023-03-01 | Cross Shawn (President & COO) | Sale | 934 | .50 | 467 |
| 2023-03-01 | Rich Douglas A. (Chief Technical Officer) | Sale | 482 | .50 | 241 |
| 2022-11-28 | Vandevender Aaron (Director) | Buy | 50,000 | 1.00 | 50,000 |
| 2022-11-25 | Vandevender Aaron (Director) | Buy | 100,000 | 1.00 | 99,700 |
| 2022-09-01 | Kanwar Bittoo (Chief Medical Officer) | Sale | 503 | 1.42 | 713 |
| 2022-09-01 | Mahmood Tahir Ph.d. (Chief Executive Officer) | Sale | 1,723 | 1.42 | 2,446 |
| 2022-09-01 | Mrsny Randall Ph.d. (Director) | Sale | 404 | 1.42 | 573 |
| 2022-09-01 | Hants Brandon (CFO) | Sale | 462 | 1.42 | 656 |
| 2022-09-01 | Cross Shawn (President & COO) | Sale | 884 | 1.42 | 1,255 |
| 2022-09-01 | Rich Douglas A. (Chief Technical Officer) | Sale | 448 | 1.42 | 636 |
| 2022-06-02 | Kanwar Bittoo (Chief Medical Officer) | Sale | 2,196 | 3.04 | 6,682 |
| 2022-06-02 | Mahmood Tahir Ph.d. (Chief Executive Officer) | Sale | 1,693 | 3.04 | 5,151 |
| 2022-06-02 | Mrsny Randall Ph.d. (Director) | Sale | 392 | 3.04 | 1,192 |
| 2022-06-02 | Hants Brandon (CFO) | Sale | 1,122 | 3.04 | 3,414 |
| 2022-06-02 | Cross Shawn (President & COO) | Sale | 2,166 | 3.04 | 6,591 |
| 2022-06-02 | Rich Douglas A. (Chief Technical Officer) | Sale | 2,602 | 3.04 | 7,917 |
| 2022-06-01 | Kanwar Bittoo (Chief Medical Officer) | Sale | 1,792 | 2.97 | 5,318 |
| 2022-06-01 | Mahmood Tahir Ph.d. (Chief Executive Officer) | Sale | 1,382 | 2.97 | 4,101 |
| 2022-06-01 | Mrsny Randall Ph.d. (Director) | Sale | 319 | 2.97 | 946 |
| 2022-06-01 | Hants Brandon (CFO) | Sale | 915 | 2.97 | 2,715 |
| 2022-06-01 | Cross Shawn (President & COO) | Sale | 1,767 | 2.97 | 5,244 |
| 2022-06-01 | Rich Douglas A. (Chief Technical Officer) | Sale | 2,123 | 2.97 | 6,301 |
| 2022-05-23 | Lamond David (Director) | Buy | 33,500 | 3.26 | 109,210 |
| 2022-05-20 | Lamond David (Director) | Buy | 33,000 | 3.08 | 101,640 |
| 2022-03-01 | Vandevender Aaron (Director) | Buy | 45,888 | 6.34 | 290,929 |
| 2022-02-28 | Vandevender Aaron (Director) | Buy | 4,112 | 6.51 | 26,769 |
| 2022-01-28 | Mahmood Tahir Ph.d. (Chief Executive Officer) | Buy | 3,000 | 7.88 | 23,640 |
| 2021-12-22 | Kanwar Bittoo (Chief Medical Officer) | Option Ex | 31,500 | 2.38 | 74,970 |
| 2021-12-09 | Mrsny Randall Ph.d. (Chief Scientific Officer) | Buy | 3,500 | 14.99 | 52,465 |
| 2021-11-17 | Epq Llc, Amtc Ps | Buy | 7,135 | 22.38 | 159,681 |
| 2021-11-16 | Epq Llc, Amtc Ps | Buy | 4,000 | 22.57 | 90,300 |
| 2021-08-27 | Kim Helen Susan (Director) | Sale | 951 | 31.10 | 29,578 |
| 2021-08-26 | Kim Helen Susan (Director) | Sale | 14,063 | 30.57 | 429,835 |
| 2021-08-25 | Kim Helen Susan (Director) | Sale | 9,478 | 30.08 | 285,079 |
| 2021-08-24 | Kim Helen Susan (Director) | Sale | 508 | 30.04 | 15,257 |
| 2021-08-23 | Cross Shawn (Chief Financial Officer) | Sale | 9,700 | 30.12 | 292,193 |
| 2021-08-23 | Cross Shawn (Chief Financial Officer) | Option Ex | 9,700 | 4.61 | 44,717 |
| 2021-08-19 | Cross Shawn (Chief Financial Officer) | Sale | 300 | 30.01 | 9,003 |
| 2021-08-19 | Cross Shawn (Chief Financial Officer) | Option Ex | 300 | 4.61 | 1,383 |
| 2021-07-21 | Bhatt Elizabeth (Chief Bus. & Strategy Officer) | Sale | 9,000 | 36.92 | 332,280 |
| 2021-07-21 | Bhatt Elizabeth (Chief Bus. & Strategy Officer) | Option Ex | 9,000 | 4.61 | 41,490 |
| 2021-07-07 | Kanwar Bittoo (Chief Medical Officer) | Sale | 7,500 | 42.84 | 321,300 |
| 2021-07-07 | Kanwar Bittoo (Chief Medical Officer) | Option Ex | 7,500 | 2.38 | 17,850 |
| 2021-07-02 | Kim Helen Susan (Director) | Sale | 200,000 | 44.80 | 8,960,600 |
| 2021-04-21 | Bhatt Elizabeth (Chief Bus. & Strategy Officer) | Sale | 9,000 | 40.30 | 362,682 |
| 2021-04-21 | Bhatt Elizabeth (Chief Bus. & Strategy Officer) | Option Ex | 9,000 | 4.61 | 41,490 |
| 2021-04-06 | Lamond David (Director) | Buy | 25,000 | 42.00 | 1,050,000 |
| 2020-07-02 | Kim Helen Susan (Director) | Option Ex | 800,000 | .02 | 16,000 |
| 2020-06-09 | Epq Llc, Amtc Ps (Other) | Buy | 2,720,000 | 14.00 | 38,080,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of AMTI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Applied Molecular Transport Inc. (symbol AMTI, CIK number 1801777) see the Securities and Exchange Commission (SEC) website.